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Abstract
Background: The 2009 flu pandemic is a global outbreak of a new strain of H1N1 influenza virus. Pandemic
influenza A (H1N1) 2009 has posed a serious public health challenge world-wide. Nepal has started Laboratory
diagnosis of Pandemic influenza A/H1N1 from mid June 2009 though active screening of febrile travellers with
respiratory symptoms was started from April 27, 2009.
Results: Out of 609 collected samples, 302 (49.6%) were Universal Influenza A positive. Among the influenza A
positive samples, 172(28.3%) were positive for Pandemic influenza A/H1N1 and 130 (21.3%) were Seasonal influenza
A. Most of the pandemic cases (53%) were found among young people with ≤ 20 years. Case Fatality Ratio for
Pandemic influenza A/H1N1 in Nepal was 1.74%. Upon Molecular characterization, all the isolated pandemic
influenza A/H1N1 2009 virus found in Nepal were antigenically and genetically related to the novel influenza
A/CALIFORNIA/07/2009-LIKE (H1N1)v type.
Conclusion: The Pandemic 2009 influenza virus found in Nepal were antigenically and genetically related to the
novel A/CALIFORNIA/07/2009-LIKE (H1N1)v type.
Background
T h e2 0 0 9f l up a n d e m i ci sag l o b a lo u t b r e a ko fan e w
strain of H1N1 influenza virus, often referred to as
swine flu [1]. The virus is a novel strain of influenza [2].
This new pandemic H1N1 influenza strain contained
genes from five different flu viruses: North American
swine influenza, North American avian influenza,
human influenza, and two swine influenza viruses typi-
cally found in Asia and Europe [3]. Due to the genetic
mutations in its hemagglutinin (HA) protein, the influ-
enza viruses can escape from the host defense mechan-
isms and thus to be able to continuously infect human
and other species [4,5].
On June 11, 2009, the ongoing outbreak of Influenza
A/H1N1 was officially declared by the WHO to be the
first influenza pandemic of the 21
st century with new
strain of Influenza A virus subtype H1N1 identified in
April 2009 [6]
. Till May 30, 2010 worldwide update by
World Health Organization (WHO) more than 214
countries have reported laboratory confirmed cases of
pandemic influenza H1N1 2009, including over 1,8,114
deaths [7].
Nepal has started screening febrile travelers with
respiratory symptoms from affected countries for the
Pandemic influenza A (H1N1) since April 27, 2009, and
the first case was detected on June 21, 2009 and intro-
duction of the disease to the country was declared on
June 29. Community transmission of Pandemic Influ-
enza A/H1N1 2009 was declared on 15 October
onwards.
This study reflects the actual outbreak situation and
its severity of Pandemic Influenza A/H1N1 in Nepal.
Methods
This is a Laboratory based prospective cross-sectional
study carried out at National Public Health Laboratory
from April 2009 to May 2010. Initially during the pan-
demic declaration of H1N1, samples were collected
from patients of all age groups from both gender meet-
ing the criteria of case definition of influenza like illness
(ILI) with history of international travel from country of
confirmed Pandemic H1N1 or close contact with
* Correspondence: southblock_arc@yahoo.com
1Department of Health Services, Molecular Virology Research Division,
National Public Health Laboratory, Kathmandu, Nepal
Full list of author information is available at the end of the article
Adhikari et al. Virology Journal 2011, 8:133
http://www.virologyj.com/content/8/1/133
© 2011 Adhikari et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.confirmed H1N1 infected persons or with shortness of
breathing or hospital admitted patients. As the commu-
nity outbreak of pandemic influenza A/H1N1 was
declared, sample collection was done by random sam-
pling method from the patients meeting case definition
of ILI. The patients already on antiviral treatment were
excluded from the study. Influenza like illness (ILI) is
defined as those who has fever ≥ 38°C with at least one
respiratory symptoms such as cough, rhinorrhoea or
sore throat [8].
Posterior pharyngeal swabs were collected into Viral
Transport Medium (VTM). For transportation from out-
side hospitals and outbreak area, Specimens were kept
on ice box (2-8°C) with bio-safety precaution and trans-
ported to the National Public Health Laboratory within
48 h after collection.
At NPHL, Laboratory diagnosis of Pandemic influenza
A/H1N1 was made by one step probe-based Real Time-
Polymerase Chain Reaction (PCR) on Posterior pharyn-
geal swabs. Initially, samples were tested for Universal
influenza A, Once Universal influenza A was positive, it
was further tested for Swine specific A followed by
Swine specific H1. According to CDC guideline, Pre-
sumptive positive for Pandemic influenza A/H1N1 was
declared if RT-PCR give positive results from either
swine A or swine/H1 or positive from both tests [9]. All
the specimens which give presumptive negative for Pan-
demic influenza A/H1N1 but universal influenza A posi-
tive were tested for seasonal influenza A (H1, H3 and
H5) and those specimens negative for all swine A/
swine/H1 and universal influenza A were tested for
Influenza B.
Quality assurance and accreditation of Molecular
Laboratory
five samples presumptive positive for Pandemic influenza
A/H1N1 at our laboratory were retested at Microbiology
Department of University of Hongkong, Hongkong and
the concurrence was 100%. We are regularly participating
in the WHO External Quality Assessment Programme
for the detection of Influenza virus type A and type B by
PCR from panel 8.
RT-PCR Technique
RNA was extracted from 140 μl aliquot of posterior
pharyngeal swabs in Viral Transport Medium (VTM) by
using viral RNA extraction kit (QIAmp, Qiagen) [10].
5 μl of RNA extract was mixed with 5.5 μlo fN u c l e a s e
free water, 0.5 μlo ff o r w a r dp r i m e r ,0 . 5μl of Reverse
primer, 0.5 μl of Probe, 0.5 μlo fS u p e r s c r i p t ™III
RT/Platinum Taq mix, 12.5 μl of 2× PCR Master Mix
making total reaction volume 25 μl.
Three separate primer/probe sets for Universal influ-
enza A(Inf A), Universal swine specific (swFluA) and
Swine specific H1 (swH1) were used. The internal posi-
tive control for human nucleic acid was RNase P pri-
mer/probe set which targets for human RNase P gene.
The primers and probes used in the RT-PCR system
were as described in Table 1.
RT-PCR system was performed as per protocol pro-
vided by Center for Disease Control, USA. The follow-
ing RT-PCR program was used in this study: Reverse
Transcription was at 50 °C for 30 min, Taq inhibitor
activation at 95 °C for 2 min, PCR amplification cycle
was at 95 °C for 15 sec and 55 °C for 30 sec with 45
times repetition. Fluorescence data (FAM) was collected
during the 55 °C incubation step [9].
Analysis in RT-PCR
When all controls i.e. Negative, Positive and human
Rnase P meet the requirements, a specimen is consid-
ered positive if the reaction growth curves cross the
threshold line within 40 cycles. Similarly, a specimen is
considered negative if growth curves do not cross the
threshold within 40 cycles [9].
Virus typing
Blindly selected few positive samples of Pandemic influ-
enza A/H1N1 from RT-PCR were sent to the WHO
reference laboratory of Center for Disease Control and
Prevention Division (CDC), Atlanta. All samples were
isolated and antigenically characterized by Haemaggluti-
nation Inhibition Assay (HAI).
Statistical tools
Statistical tools like Probability were calculated by using
Statistical Package for the Social Sciences (SPSS)
programme.
Results
A total of 609 patients with suspected Pandemic influ-
enza A/H1N1 were tested at National public health
laboratory during the study period. All the samples were
confirmed by Real-Time PCR. Out of these samples, 172
(28.3%) were Pandemic influenza A/H1N1 positive and
130 (21.34%) cases were seasonal influenza A as in
Table 2. Due to heavy work load and priority for identi-
fication of pandemic H1N1, all the Seasonal influenza-A
positive cases were not sub-typed. A sub-set of 88 seaso-
nal-A positive samples, till November 2009 were sub-
typed and found 70(79.5%) were seasonal H3, 8(9.09%)
were seasonal H1 and 10(11.36%) were unsubtypeable
seasonal influenza A. Among 219 negative cases for
Universal Influenza A were tested for Influenza B and
found only one positive case.
Ten randomly selected positive cases of Pandemic
influenza A/H1N1 by RT-PCR were isolated and antige-
nically characterized by Haemagglutination Inhibition
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2009. All the characterized virus found in Nepal were
antigenically and genetically related to the novel influ-
enza A/CALIFORNIA/07/2009-LIKE (H1N1)v type (Fig-
ure 1).
First case of Pandemic influenza A/H1N1 was
detected in June 2009. Starting from the June, cases
were increasing up to peak of the Pandemic Influenza
outbreak in November (Figure 2).
Till May 2010, total number of confirmed positive
cases of Pandemic influenza A/H1N1 was 172. Out of
them, 36 cases were recorded before declaration of
Community transmission among 29 Nepalese citizens
residing within the country or from abroad, 2 foreigner,
5 close relatives of confirmed positive cases and remain-
ing 136 cases were found after community transmission
which was declared on October 15 2009.
Travelling history of pandemic influenza cases before
community transmission was as shown in Figure 3.
Among them, largest no of cases were found from US.
After community outbreak, most of the cases of Pan-
demic influenza were from Kathmandu district followed
by Kaski and Chitwan (Figure 4).
All the confirmed cases of Pandemic influenza A/
H1N1 were in the range of age group from 1-74 with
mean age 21 years. Most of the cases were found in the
age group 11-20 followed by 21-30 and 0-10. Among
the positive cases 119(69.18%) were male and 28
(30.82%) were female (Figure 5 and 6).
Till May 2010, three death cases were reported due to
Pandemic influenza A/H1N1. All were
Female patients with age 31, 29 and 23 (Figure 7).
Discussion
Since the middle of March 2009, infections with the new
influenza A (H1N1) strain started to occur in Mexico,
and the first two cases in the United States occurred in
late March 2009, although they were not confirmed
until April 15, 2009 [11]. The rapid global spread indi-
cates towards the influence of international air travel on
influenza [12]. According to the data from WHO till
March 2010, this new influenza A (H1N1) was esti-
mated to have a case-fatality rate (CFR) of 1.28%.
In this study, by May 28 2010, a total of 609 suspected
patients were tested for Pandemic influenza A/H1N1
2009. Out of the collected samples, 130 (21.34%) were
seasonal influenza A positive and 172 (28.3%) were Pan-
demic influenza A/H1N1 positive. The mean age of
patients with confirmed Pandemic influenza A/H1N1
was 21, whereas the mean age of the positive cases of
Seasonal influenza A was 28. Patients with pandemic
(H1N1) 2009 were significantly younger (p = 0.04,
c2 = 8.21) than patients with Seasonal influenza A
(< 20 years).
A characteristic feature of the H1N1 pandemic is that
it disproportionately affected so far children and young
adults [13]. Similar results were observed in different
parts of the world: In Saudi Arabia, the age of the cases
ranged between 1 and 56 years with mean (SD) of 24.2
(14.4) years [14]. One of the early studies from the USA
showed that although the age of pandemic influenza A
(H1N1) patients in the study ranged from 3 months to
81 years, 60% of patients were 18 years of age or
younger. In most countries, the majority of Pandemic
influenza A (H1N1) cases have been occurring in young
Table 1 Primers and Probe sets used for the diagnosis of Pandemic Influenza A/H1N1
Primers and Probes Sequence (5’ >3
’) Working Concentration
Inf A Forward GAC CRA TCC TGT CAC CTC TGA C 40 μM
Inf A Reverse AGG GCA TTY TGG ACA AAK CGT CTA 40 μM
Inf A Probe TGC AGT CCT CGC TCA CTG GGC ACG 10 μM
SW Inf A Forward GCA CGG TCA GCA CTT ATY CTR AG 40 μM
SW Inf A Reverse GTG RGC TGG GTT TTC ATT TGG TC 40 μM
SW Inf A Probe CYA CTG CAA GCC CA “T” ACA CAC AAG CAG GCA 10 μM
SW H1 Forward GTG CTA TAA ACA CCA GCC TYC CA 40 μM
SW H1 Reverse CGG GAT ATT CCT TAA TCC TGT RGC 40 μM
SW H1 Probe CA GAA TAT ACA “T"CC RGT CAC AAT TGG ARA A 10 μM
RnaseP Forward AGA TTT GGA CCT GCG AGC G 40 μM
RnaseP Reverse GAG CGG CTG TCT CCA CAA GT 40 μM
RnaseP Probe TTC TGA CCT GAA GGC TCT GCG CG 10 μM
Table 2 Total cases of Suspected Pandemic influenza A/H1N1 (n = 609)
Cases Universal Influenza A Pandemic Influenza A/H1N1 Seasonal Influenza A
Positive 302(49.6%) 172(28.3%) 130(21.34%)
Negative 307(50.4%) 437(71.77%) 479(78.66%)
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17 years in Canada, the USA, Chile, Japan, and the UK.
Most of the pandemic influenza cases in young age peo-
ple indicate towards partial immunity to the virus in the
older population [15].
The overall case fatality ratio (CFR) found in this
study was 1.74% as 3 death cases were reported till May
28, 2010. All the death cases were found in female with
below 35 years of age. The data found in this study is
similar with the other literatures. The overall case
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Figure 1 The neighbor joining tree of influenza A/H1N1 (Swine) 2009 complete HA gene (1,701 bp).
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Figure 3 Travel history of confirmed Pandemic influenza A/H1N1cases before community transmission (n = 36).
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Page 5 of 8fatality rate has been less than 0.5%, and the wide range
of estimates (0.0004 to 1.47%) reflects uncertainty regard-
ing case ascertainment and the number of infections
[16-18]. The case fatality rate for symptomatic illness was
estimated to be 0.048% in the United States [19] and
0.026% in the United Kingdom [20]. In contrast to seaso-
nal influenza, most of the serious illnesses caused by the
pandemic virus have occurred among children and
nonelderly adults, and approximately 90% of deaths have
occurred in those under 65 years of age [21].
Conclusion
In Nepal, mostly young aged people were affected by the
wave of this pandemic influenza and all the isolated pan-
demic influenza A/H1N1 2009 virus were antigenically
Figure 4 District wise distribution of total Pandemic influenza A/H1N1 cases after community transmission (n = 136).
Figure 5 Age wise distribution of confirmed Pandemic influenza A/H1N1 cases (n = 172).
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Gender wise distribution of cases
Female, 
53
Male, 119
Figure 6 Sex wise distribution of confirmed Pandemic influenza A/H1N1 cases (n = 172).

2
nd case, Bhaktapur-Jadibuti, 
Female- 29 
1
st case Chitwan, 
Madi, Female- 31 
3rd case 
Kathmandu,Female-
23
Figure 7 Information of death cases in Nepal by Pandemic influenza A/H1N1.
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Page 7 of 8and genetically related to the novel A/CALIFORNIA/07/
2009-LIKE (H1N1)v type.
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